Articles From: Imprimis Pharmaceuticals Expands Proprietary Ophthalmic Formulations to Four Key Western States to In An Exclusive Interview With Cooking Light, First Lady Michelle Obama Talks About The State Of Family Dinner & How She Will Measure The Success Of Let's Move!


2014/12/3
Dropless Cataract Therapy now available in California, Nevada, Oregon, and Hawaii SAN DIEGO , Dec.
Sign-up for Imprimis Pharmaceuticals Expands Proprietary Ophthalmic Formulations to Four Key Western States investment picks
2015/1/8
Proprietary topical compounded formulations offer the promise of significantly reducing the number of patient eye drop administrations as well as the high cost of eye drops typically required for traditional treatment Results of an investigator-initiated evaluation of the company's Pred-Moxi and Tri-Moxi topical eye drops for patients following LASIK surgery expected to be announced by end of January 2015 SAN DIEGO , Jan.
Sign-up for Imprimis Pharmaceuticals Looks to Expand its Ophthalmology Portfolio with LessDrops™ investment picks
2014/12/2
Agreement to acquire Park Compounding marks an important milestone and a significant step forward to achieving nationwide distribution capability for Imprimis' patent-pending ophthalmic and urologic formulations SAN DIEGO , Dec.
Sign-up for Imprimis Pharmaceuticals Signs Agreement to Acquire PCAB-Accredited Pharmacy in California investment picks
2015/1/13
Dropless Therapy™ injectable and planned LessDrops™ topical compounded formulations offer the same patent-pending technology and the promise of significantly reducing or completely eliminating the number of patient eye drop administrations.
Sign-up for Imprimis Pharmaceuticals to Highlight its Proprietary Ophthalmic Solutions at the Hawaiian Eye 2015 and the Cataract Surgery: Telling It Like It Is! Meetings investment picks
2015/2/24
Imprivata® (NYSE: IMPR), the healthcare IT security company, today announced financial results for the fourth quarter and full year of fiscal 2014.
Sign-up for Imprivata Achieves Record Fourth Quarter, Full-Year Revenues investment picks
2015/1/14
Imprivata ® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today announced that Imprivata Cortext ® is the first secure communications platform for healthcare to integrate with XenMobile ®, a comprehensive enterprise mobility management (EMM) solution developed by Citrix.
Sign-up for Imprivata Announces First Secure Communications Solution for Healthcare to Integrate with Citrix XenMobile investment picks
2015/2/10
Imprivata ® (NYSE: IMPR), the healthcare IT security company, today announced that the company will release the results for its fourth quarter and the full year ended December 31, 2014 after the market closes on Wednesday, February 25, 2015.
Sign-up for Imprivata Announces Fourth Quarter and Full Year 2014 Earnings Conference Call investment picks
2015/1/12
Imprivata® (NYSE: IMPR) today announced that it expects its fourth quarter 2014 revenue to exceed the upper end of its previously announced guidance range of $26 to $27 million.
Sign-up for Imprivata Announces Record Revenues for 4Q2014 investment picks
2015/2/11
Imprivata ® (NYSE: IMPR), the healthcare IT security company, today announced a revised date for its fourth quarter and the full year ended December 31, 2014 conference call.
Sign-up for Imprivata Announces Revised Fourth Quarter and Full Year 2014 Earnings Release Date investment picks
2015/2/9
Imprivata ® (NYSE:IMPR), the healthcare IT security company, today launched Imprivata Confirm ID ™, the industry’s first comprehensive product to enable a major shift from paper to electronic prescribing of controlled substances (EPCS). Imprivata Confirm ID simplifies adoption of regulatory requirements for EPCS, helping care providers address the workflow inefficiencies and potential for fraud caused by paper-based prescriptions.
Sign-up for Imprivata Launches New Product to Enable Major Shift to Electronic Prescribing of Controlled Substances investment picks
2014/12/2
Imprivata ® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today introduced Imprivata OneSign ® 5.0 , the newest version of the company’s flagship authentication and access management solution.
Sign-up for Imprivata OneSign 5.0 Expands Capabilities of Healthcare Industry’s Leading Solution for Authentication Management and Virtual Desktop Access investment picks
2015/2/17
Imprivata ® (NYSE:IMPR), the healthcare IT security company, today announced a partnership with Symantec to provide a comprehensive fingerprint biometric and FICAM-certified Credential Service Provider (CSP) solution for electronic prescribing of controlled substances (EPCS) .
Sign-up for Imprivata Partners with Symantec to Provide Comprehensive Fingerprint Biometric and Token Solution for Electronic Prescribing of Controlled Substances investment picks
2014/12/18
Imprivata® (NYSE: IMPR) today announced that members of management will participate in the 33rd Annual J.P. Morgan Healthcare Conference.
Sign-up for Imprivata to Present at The 33rd Annual J.P. Morgan 2015 Healthcare Conference investment picks
2015/2/26
Imprivata® (NYSE: IMPR), the healthcare IT security company, today announced that members of management will participate in the upcoming Barclays Global Healthcare Conference.
Sign-up for Imprivata to Present at The Barclays Global Healthcare Conference investment picks
2014/12/19
Praxair, Inc. (NYSE:PX) announced today that the company will exhibit its most recent product introductions at the International Production and Processing Expo (IPPE) in Atlanta, Ga., January 27–29, 2015.
Sign-up for Improved Productivity for Processors: ColdFront™ Cryogenic Systems Featuring the ColdFront™ Cryo-Saver Tunnel Freezer at IPPE investment picks
2015/2/9
The Finish Line, Inc. (NASDAQ: FINL), a premium retailer of athletic shoes, apparel and accessories, announced today that Imran Jooma has joined the company as chief omnichannel officer and executive vice president.
Sign-up for Imran Jooma Joins Finish Line as Chief Omnichannel Officer, Executive Vice President investment picks
2014/12/24
MINNEAPOLIS , Dec.
Sign-up for IMRIS Announces Closing of Private Placement Offering of Units investment picks
2014/12/22
MINNEAPOLIS, MN , Dec.
Sign-up for IMRIS Announces Private Placement Offering of Units and Other Corporate Developments investment picks
2014/12/1
18 US neurosurgeons from 9 leading institutions validate robot usability for final 510(k) submission deliverable MINNEAPOLIS, MN , Dec.
Sign-up for IMRIS completes SYMBIS Surgical System human factors study investment picks
2015/2/17
IMRIS Regains Compliance with NASDAQ Listing Requirements Canada NewsWire MINNEAPOLIS, MN , Feb.
Sign-up for IMRIS Regains Compliance with NASDAQ Listing Requirements investment picks
2015/2/17
MINNEAPOLIS, MN , Feb.
Sign-up for IMRIS Regains Compliance with NASDAQ Listing Requirements investment picks
2015/2/26
IMRIS to Hold Fourth Quarter and Annual 2014 Financial Results Conference Call Canada NewsWire MINNEAPOLIS, MN , Feb.
Sign-up for IMRIS to Hold Fourth Quarter and Annual 2014 Financial Results Conference Call investment picks
2015/2/26
MINNEAPOLIS, MN , Feb.
Sign-up for IMRIS to Hold Fourth Quarter and Annual 2014 Financial Results Conference Call investment picks
2014/12/29
IMS Health (NYSE:IMS) Chairman and Chief Executive Officer Ari Bousbib will speak at the J.P. Morgan 33rd Annual Healthcare Conference in San Francisco, California on Tuesday, January 13, 2015 at 2:00 p.m. PST/ 5:00 p.m. EST.
Sign-up for IMS Health Chairman & CEO Ari Bousbib to Speak at J.P. Morgan 33rd Annual Healthcare Conference on January 13 investment picks
2014/12/16
IMS Health (NYSE:IMS) today announced that Mason Tenaglia has been appointed vice president, Payer & Managed Care Insights, IMS Institute for Healthcare Informatics, a new position.
Sign-up for IMS Health Names Mason Tenaglia Vice President, Payer & Managed Care Insights, IMS Institute for Healthcare Informatics investment picks
2014/12/19
IMS Health (NYSE:IMS) today announced that the company has received approval from the European Commission in connection with the pending acquisition of certain Cegedim information solutions and customer relationship management (CRM) businesses.
Sign-up for IMS Health Receives Regulatory Clearance for Cegedim Transaction investment picks
2015/2/3
IMS Health Holdings , Inc. (“IMS Health”) (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced results for the quarter and year ended December 31, 2014.
Sign-up for IMS Health Reports Fourth-Quarter and Full-Year 2014 Results, Issues Full-Year 2015 Guidance investment picks
2015/1/21
IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS) will issue its fourth-quarter and full-year 2014 financial results before the market opens on Tuesday, February 3, 2015.
Sign-up for IMS Health to Announce Full-Year and Fourth-Quarter 2014 Results On February 3, 2015 investment picks
2014/12/18
New approaches for determining how much drugs should cost, and for setting the price for innovative treatments, were highlighted in a keynote presentation by Murray Aitken, IMS Health senior vice president and executive director of the IMS Institute for Healthcare Informatics, at the Forbes Healthcare Summit held earlier this month in New York City.
Sign-up for IMS Institute Identifies Innovative Payment Models for Pharmaceuticals at Forbes Healthcare Summit investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Imprimis Pharmaceuticals Expands Proprietary Ophthalmic Formulations to Four Key Western States to In An Exclusive Interview With Cooking Light, First Lady Michelle Obama Talks About The State Of Family Dinner & How She Will Measure The Success Of Let's Move!
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent